Bioceres Crop Solutions Corp.
For the period ended May 12, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
May 12, 2026 · Filed May 12, 2026
Use the contents to explore the available documents and sections.
BIOX$0.23+10.2%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Financial & Business Highlights
Financial & Business Highlights
| ● | Total revenues were $39.4 million in 3Q26, a 23% year-over-year decline, reflecting softer demand and competitive pressures in Crop Protection, together with the ongoing transition in Seeds. Crop Nutrition revenues increased 15% during the quarter. |
| ● | Gross profit was $12.7 million, with gross margin of 32%, reflecting lower revenues and product mix effects across segments. Crop Nutrition results were impacted by a non-recurring obsolescence adjustment in inoculants related to inventory normalization efforts. |
| ● | SG&A expenses declined 16% year over year, reflecting continued execution of organizational streamlining and cost management initiatives across the continuing operations. |
| ● | Net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million, primarily reflecting lower gross profit and the absence of prior-year non-cash income associated with the reorganization in Seeds. |
| ● | Following the Pro Farm foreclosure auction earlier this year, and the related noteholder dispute, the Company continued advancing liability management initiatives across its operating subsidiaries, including debt reprofiling efforts and a voluntary bond maturity extension process in Argentina. |
| 2 | BIOCERES CROP SOLUTIONS | THIRD QUARTER 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.